Renal and hepatic dose adjustment in children

Overview & Definition

A child walks in. You reach for a drug. The textbook dose is a dose for a child with normal kidneys and a normal liver. The moment either organ falters, that textbook dose becomes a guess — and for some drugs a dangerous one. Dose adjustment is the deliberate act of changing the dose, the interval, or both so that the same drug stays inside its therapeutic window when the clearance machinery is impaired. ^[5]

The reason this matters so much in children is twofold. Children are small, so a small arithmetic error is a large relative error. And children's organ function is not static: a neonate's filtration is a fraction of an adult's, a dehydrated toddler's filtration can collapse in hours, and a transplanted teenager's can swing with each tacrolimus level. A safe prescription in paediatrics is therefore never a one-off number; it is a number tied to a measured organ function and a plan to recheck it. ^[1]

Two organs dominate the question. The kidney clears water-soluble drugs and their metabolites, so when glomerular filtration falls, those drugs and their active metabolites accumulate. The liver clears fat-soluble drugs by metabolism (mostly the cytochrome P450 system) and by bile flow, so when hepatic blood flow, enzyme capacity, or synthetic function fall, those drugs hang around too long. Most dose-adjustment decisions you will make at the bedside are about one of these two organs, and a surprising number — the septic child in shock, the cirrhotic with an infection — are about both at once. ^{[5] [6]}

Three terms will recur, and examiners expect you to use them precisely. Dose reduction means giving less drug per dose. Interval extension means leaving more time between doses. Therapeutic drug monitoring (TDM) means measuring the drug in the blood and using the result to titrate. These are not interchangeable. Aminoglycosides are concentration-dependent killers, so for them you usually extend the interval rather than shrink the dose. Vancomycin is time-dependent, so you often adjust both. Understanding why each tool fits each drug is the difference between a memorised rule and a defensible prescription. ^[7]

Finally, a framing rule that will keep you safe: the loading dose usually still applies, and the maintenance dose is what falls. A loading dose depends on the volume of distribution, which often does not change much in organ failure (and may rise in fluid overload). Clearance is what falls. So load to fill the tank, then slow the refill. This single principle prevents two common errors — under-treating a sick child by withholding a needed load, and poisoning them by maintaining a normal rate. ^[5]

References12ShowHide

1. [1]Schwartz GJ New equations to estimate GFR in children with CKD J Am Soc Nephrol, 2009.PMID 19158356
2. [2]Ng DK Self-reported Race, Serum Creatinine, Cystatin C, and GFR in Children and Young Adults With Pediatric Kidney Diseases: A Report From the Chronic Kidney Disease in Children (CKiD) Study Am J Kidney Dis, 2022.PMID 34974031
3. [3]Pottel H Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate Ann Intern Med, 2021.PMID 34280339
4. [4]Stevens PE Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline Ann Intern Med, 2013.PMID 23732715
5. [5]Verbeeck RK Pharmacokinetics and dosage adjustment in patients with renal dysfunction Eur J Clin Pharmacol, 2009.PMID 19543887
6. [6]Verbeeck RK Effect of hepatic insufficiency on pharmacokinetics and drug dosing Pharm World Sci, 1998.PMID 9820880
7. [7]Rybak MJ Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists Am J Health Syst Pharm, 2020.PMID 32191793
8. [8]Zhang T Revised therapeutic window for vancomycin in pediatric patients: evidence from a retrospective therapeutic drug monitoring study BMC Pharmacol Toxicol, 2025.PMID 41254740
9. [9]Han J Implementation of Vancomycin Therapeutic Monitoring Guidelines: Focus on Bayesian Estimation Tools in Neonatal and Pediatric Patients Ther Drug Monit, 2022.PMID 34145165
10. [10]Soeorg H Pharmacokinetics of Gentamicin Components C1, C1a, and C2/C2a/C2b and Subsequent Decline in Glomerular Filtration Rate in Neonates AAPS J, 2022.PMID 35760955
11. [11]Holsteen PE Nephrotoxic Exposures and Acute Kidney Injury in Noncritically Ill Children Stratified by Service Hosp Pediatr, 2022.PMID 36102129
12. [12]Gavigan HW Blood transfusion rates in Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action)-a single-center experience Pediatr Nephrol, 2021.PMID 33479823